日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Discovery of 5-Azaquinoxaline Derivatives as Potent and Orally Bioavailable Allosteric SHP2 Inhibitors

发现5-氮杂喹喔啉衍生物作为高效且口服生物利用度高的变构SHP2抑制剂

Elsayed, Mohamed S A; Blake, James F; Boys, Mark L; Brown, Eric; Chapsal, Bruno D; Chicarelli, Mark J; Cook, Adam W; Fell, Jay B; Fischer, John P; Hanson, Lauren; Lemieux, Christine; Martinson, Matthew C; McCown, Joseph; McNulty, Oren T; Mejia, Macedonio J; Neitzel, Nickolas A; Otten, Jennifer N; Rodriguez, Martha E; Wilcox, Daniel; Wong, Christina E; Zhou, Yeyun; Hinklin, Ronald J

Indenoisoquinoline Topoisomerase Inhibitors Strongly Bind and Stabilize the MYC Promoter G-Quadruplex and Downregulate MYC

茚并异喹啉类拓扑异构酶抑制剂能强力结合并稳定MYC启动子G-四链体,从而下调MYC表达。

Wang, Kai-Bo; Elsayed, Mohamed S A; Wu, Guanhui; Deng, Nanjie; Cushman, Mark; Yang, Danzhou

Synthesis and Biological Evaluation of the First Triple Inhibitors of Human Topoisomerase 1, Tyrosyl-DNA Phosphodiesterase 1 (Tdp1), and Tyrosyl-DNA Phosphodiesterase 2 (Tdp2).

人类拓扑异构酶 1、酪氨酰-DNA 磷酸二酯酶 1 (Tdp1) 和酪氨酰-DNA 磷酸二酯酶 2 (Tdp2) 的首个三重抑制剂的合成和生物学评价

Wang Ping, Elsayed Mohamed S A, Plescia Caroline B, Ravji Azhar, Redon Christophe E, Kiselev Evgeny, Marchand Christophe, Zeleznik Olga, Agama Keli, Pommier Yves, Cushman Mark